Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
15.17
-0.09 (-0.59%)
At close: Feb 27, 2026, 4:00 PM EST
15.19
+0.02 (0.13%)
After-hours: Feb 27, 2026, 4:55 PM EST
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.67 billion as of February 27, 2026. Its market cap has increased by 593.19% in one year.
Market Cap
1.67B
Enterprise Value
1.33B
1-Year Change
593.19%
Ranking
Category
Stock Price
$15.17
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.67B, an increase of 55.81%. That is a compound annual growth rate of 11.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.67B | 25.58% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phibro Animal Health | 2.25B |
| Bausch Health Companies | 2.24B |
| Harrow | 1.95B |
| BioCryst Pharmaceuticals | 1.94B |
| Perrigo Company | 1.89B |
| ANI Pharmaceuticals | 1.60B |
| Collegium Pharmaceutical | 1.40B |
| Alvotech | 1.28B |